RBMY2DP

RNA expression — cross-omics
Cross-omicsRNA → MUTATIONPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RBMY2DP RNA expression is significantly associated with the mutation status of many other genes, with 88 significant associations in total. BRCA shows the largest number of these associations.

The most reproducible RBMY2DP-associated genes across cancer lineages are RASL11B, HCLS1, and SYNPO2. Each is linked with RBMY2DP in more than 1 cancer types. Because this analysis shows association rather than direction, both RBMY2DP-to-partner and partner-to-RBMY2DP results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RBMY2DP→partner) and Y-score (partner→RBMY2DP) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCARASL11B →+9.057+0.029.003<.00132
BRCAHCLS1 →+7.473+0.014.007<.00132
STADSYNPO2 →+4.136+0.005.005<.00132
BRCADAAM1 →+7.473+0.029.007<.00131
BRCAISM2 →+7.473+0.014.007<.00131
BRCALILRA1 →+7.057+0.011.009<.00131
Each partner links to its Q-omics profile. Showing the 6 strongest of 88 associations by consensus.

Exploration